Tekla Capital Management LLC Astrazeneca PLC Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Tekla Capital Management LLC holds 976,676 shares of AZN stock, worth $76.4 Million. This represents 2.77% of its overall portfolio holdings.

Number of Shares

976,676

Previous 992,664 1.61%

Holding current value

$76.4 Million

Previous $68.9 Million 1.45%

% of portfolio

2.77%

Previous 2.64%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$69.91 - $75.81 $1.12 Million - $1.21 Million	-15,988 Reduced 1.61%	976,676 $69.9 Million
Q1 2023 May 10, 2023	SELL	$63.15 - $71.6 $1.87 Million - $2.12 Million	-29,591 Reduced 2.89%	992,664 $68.9 Million
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $13.6 Million - $17.7 Million	-250,938 Reduced 19.71%	1,022,255 $69.3 Million
Q3 2022 Nov 01, 2022	BUY	$53.02 - $135.75 $7.87 Million - $20.2 Million	148,452 Added 13.2%	1,273,193 $69.8 Million
Q2 2022 Jul 29, 2022	BUY	$59.26 - $71.14 $7.94 Million - $9.54 Million	134,066 Added 13.53%	1,124,741 $74.3 Million

Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $11.3 Million - $13.6 Million	203,190 Added 25.8%	990,675 $65.7 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $1.37 Million - $1.62 Million	-25,442 Reduced 3.13%	787,485 $45.9 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $20.3 Million - $22.2 Million	364,629 Added 81.34%	812,927 $48.8 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $5.03 Million - $6.26 Million	103,965 Added 30.19%	448,298 $26.9 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $5.81 Million - $6.69 Million	109,535 Added 46.65%	344,333 $18.9 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $1.78 Million - $2.28 Million	-41,300 Reduced 14.96%	234,798 $12.4 Million
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $2.36 Million - $2.68 Million	-58,900 Reduced 17.58%	276,098 $12.3 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $969,280 - $1.08 Million	-26,000 Reduced 7.2%	334,998 $13.8 Million
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $2.38 Million - $2.88 Million	-67,026 Reduced 15.66%	360,998 $14.6 Million
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $10.7 Million - $12.1 Million	-290,600 Reduced 40.44%	428,024 $16.3 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $2.09 Million - $2.39 Million	-60,264 Reduced 7.74%	718,624 $28.4 Million
Q2 2018 Aug 13, 2018	BUY	$34.55 - $37.05 $11.6 Million - $12.5 Million	336,288 Added 75.98%	778,888 $27.3 Million
Q3 2017 Nov 13, 2017	SELL	$28.96 - $34.0 $3.13 Million - $3.67 Million	-108,000 Reduced 19.61%	442,600 $15 Million
Q2 2017 Aug 14, 2017	BUY	N/A	550,600	550,600 $18.8 Million

Others Institutions Holding AZN

# of Institutions

1,246

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Astrazeneca PLC Transaction History